Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 4
1980 8
1981 4
1982 2
1983 6
1984 5
1985 3
1986 5
1987 6
1988 9
1989 7
1990 6
1991 3
1992 6
1993 3
1994 6
1995 3
1996 6
1997 12
1998 15
1999 10
2000 6
2001 10
2002 9
2003 15
2004 21
2005 19
2006 23
2007 24
2008 33
2009 37
2010 42
2011 39
2012 56
2013 50
2014 52
2015 56
2016 76
2017 92
2018 140
2019 107
2020 130
2021 160
2022 182
2023 190
2024 162
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,652 results

Results by year

Filters applied: . Clear all
Page 1
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study.
Lee SM, Schulz C, Prabhash K, Kowalski D, Szczesna A, Han B, Rittmeyer A, Talbot T, Vicente D, Califano R, Cortinovis D, Le AT, Huang D, Liu G, Cappuzzo F, Reyes Contreras J, Reck M, Palmero R, Mak MP, Hu Y, Morris S, Höglander E, Connors M, Biggane AM, Vollan HK, Peters S. Lee SM, et al. Among authors: le at. Lancet. 2023 Aug 5;402(10400):451-463. doi: 10.1016/S0140-6736(23)00774-2. Epub 2023 Jul 6. Lancet. 2023. PMID: 37423228 Clinical Trial.
Risk factors for eating disorders: findings from a rapid review.
Barakat S, McLean SA, Bryant E, Le A, Marks P; National Eating Disorder Research Consortium; Touyz S, Maguire S. Barakat S, et al. Among authors: le a. J Eat Disord. 2023 Jan 17;11(1):8. doi: 10.1186/s40337-022-00717-4. J Eat Disord. 2023. PMID: 36650572 Free PMC article. Review.
The Heterogeneity of Liver Cancer Metabolism.
Salazar J, Le A. Salazar J, et al. Among authors: le a. Adv Exp Med Biol. 2021;1311:127-136. doi: 10.1007/978-3-030-65768-0_9. Adv Exp Med Biol. 2021. PMID: 34014539 Free PMC article.
Deucravacitinib in the treatment of psoriasis.
Estevinho T, Lé AM, Torres T. Estevinho T, et al. Among authors: le am. J Dermatolog Treat. 2023 Dec;34(1):2154122. doi: 10.1080/09546634.2022.2154122. Epub 2022 Dec 13. J Dermatolog Treat. 2023. PMID: 36453809 Free article. Review.
Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function.
Hogan BL, Barkauskas CE, Chapman HA, Epstein JA, Jain R, Hsia CC, Niklason L, Calle E, Le A, Randell SH, Rock J, Snitow M, Krummel M, Stripp BR, Vu T, White ES, Whitsett JA, Morrisey EE. Hogan BL, et al. Among authors: le a. Cell Stem Cell. 2014 Aug 7;15(2):123-38. doi: 10.1016/j.stem.2014.07.012. Cell Stem Cell. 2014. PMID: 25105578 Free PMC article. Review.
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial.
Li J, Qin S, Xu R, Yau TC, Ma B, Pan H, Xu J, Bai Y, Chi Y, Wang L, Yeh KH, Bi F, Cheng Y, Le AT, Lin JK, Liu T, Ma D, Kappeler C, Kalmus J, Kim TW; CONCUR Investigators. Li J, et al. Among authors: le at. Lancet Oncol. 2015 Jun;16(6):619-29. doi: 10.1016/S1470-2045(15)70156-7. Epub 2015 May 13. Lancet Oncol. 2015. PMID: 25981818 Clinical Trial.
1,652 results